GL1X · GenesisL1 explorer

Research workbench

Crystal structure of stabilized tem-1 beta-lactamase variant V.13 carrying R164S mutation in complex with boron-based inhibitor EC25

Analyse Crystal structure of stabilized tem-1 beta-lactamase variant V.13 carrying… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4OQH
Type
protein
Length
263 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Extended spectrum beta-lactamase tem-63
UniProt
Q9AGJ5
Ligands
2UL, CA
Pockets
1 · best druggability 0.39

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AExtended spectrum beta-lactamase tem-63protein26344% helix, 17% strandQ9AGJ5

Ligands and binding sites

  • 2UL · 3-[(2R)-2-{[(2R)-2-amino-2-phenylacetyl]amino}-2-(dihydroxyboranyl)ethyl]benzoic acid · ligand · chains A
  • CA · Calcium ion · metal · chains A
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1940.390.77192UL

Modifications

Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

  • 4OQH · Crystal structure of stabilized TEM-1 beta-lactamase variant v.13 carrying R164S mutation… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.